Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

More Than Meets the Eye

Jason Liebowitz, MD, FACR  |  November 21, 2023

Mimics & More

Dr. Ogdie

Dr. Ogdie-Beatty

The final speaker in the session was Alexis Ogdie-Beatty, MD, MSCE, associate professor of medicine, associate professor of epidemiology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia. Dr. Ogdie-Beatty explained that, when evaluating for nr-axSpA, a rheumatologist should always be asking, “What else could this be?”

The list of potential mimicking conditions is long and includes mechanical back pain, fibromyalgia, degenerative disc disease, fracture, osteitis condensans ilii, diffuse idiopathic skeletal hyperostosis (DISH), sarcoidosis, crystalline arthritis and septic arthritis.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

One key question with which to begin the evaluation is to ask, “Where is the pain?” The specific location of pain, as well as patient age, precipitating factors and relationship to physical activity, will often help inform if this is more or less likely to be mechanical back pain.

Dr. Ogdie-Beatty explained that inflammatory back pain is typically associated with an insidious onset, is worse at night (especially the second half of the night) and improves with activity.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In speaking about other causes of back pain, fibromyalgia is challenging because it can both mimic inflammatory back pain as well as exist as a comorbidity in up to one-third of patients with axSpA.

Osteitis condensans ilii is characterized by benign sclerosis of the ilium adjacent to the SI joints, often appearing bilaterally and with a triangular shape. The condition is more common in women than men, particularly during and after pregnancy. DISH is normally found in men over age 45 and is associated with the presence of diabetes mellitus. It may be asymptomatic and present mostly as decreased range of motion in the spine; enthesophytes are also commonly seen with this condition.

Some other mimics of inflammatory back pain, such as Paget’s disease, X-linked hypophosphatemia and alkaptonuric ochronosis (an autosomal recessive disease that results in buildup of homogentisic acid in cartilage and subsequent arthropathy) are quite rare, but worth at least being aware of.

In Sum

The session was stimulating and highly informative, which comes as a great relief to the rheumatology world that is still trying to better understand the entity of nr-axSpA.


Jason Liebowitz, MD, is an assistant professor of medicine in the Division of Rheumatology at Columbia University Vagelos College of Physicians and Surgeons, New York.

Reference

  1. Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection [published correction appears in Ann Rheum Dis. 2019 Jun;78(6):e59]. Ann Rheum Dis. 2009;68(6):777–783.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ACR ConvergenceAxial SpondyloarthritisConditionsMeeting ReportsPsoriatic Arthritis Tagged with:ACR Convergence 2023ACR Convergence 2023 PsAAS Resource Center

Related Articles
    Andrew Brookes / Image Source on Offset

    Clinical Insights into Axial Spondyloarthritis: Rheumatology Drugs at a Glance, Part 5

    February 10, 2022

    Over the past few years, biosimilars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug options; others have few or only off-label options. This series, Rheumatology Drugs at a Glance, provides streamlined information on the administration of biologic, biosimilar and other medications used to…

    Top Research in Axial Spondyloarthritis Presented at ACR Convergence 2022

    November 18, 2022

    PHILADELPHIA—Approximately 100 research abstracts on axial spondyloarthritis (axSpA) were accepted for presentation at ACR Convergence 2022. It is exciting to see a wealth of research on axSpA being undertaken worldwide. Here, we highlight important points from 10 of these studies. 1. Abstract 0378: Prevalence of Axial Spondyloarthritis (axSpA) in Patients Treated for Chronic Back Pain…

    Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis

    May 1, 2014

    New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation

    Axial Disease in Psoriatic Arthritis

    May 6, 2022

    When Moll and Wright first described the spondyloarthritides in the early 1970s, the archetype of the group was ankylosing spondylitis (AS).1 The shared clinical features of the spondyloarthritides were sacroiliitis; asymmetric large joint peripheral arthritis; psoriasis or psoriaform skin lesions, including keratoderma blennorrhagica; uveitis; and bowel inflammation. Moll and Wright described five clinical subgroups of…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences